Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Vercruysse, M. Ziebell, G. Prestwich (1999)
Control of enzymatic degradation of hyaluronan by divalent cations.Carbohydrate research, 318 1-4
P. Bulpitt, Daniel Aeschlimann (1999)
New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels.Journal of biomedical materials research, 47 2
Thomas Rj, Phillips Re (1995)
The role of material surface chemistry in implant device calcification: a hypothesis.Journal of Heart Valve Disease, 4
R. Feinberg, D. Beebe (1983)
Hyaluronate in vasculogenesis.Science, 220 4602
Weiliam Chen, F. Schoen, R. Levy (1994)
Mechanism of Efficacy of 2‐Amino Oleic Acid for Inhibition of Calcification of Glutaraldehyde‐Pretreated Porcine Bioprosthetic Heart ValvesCirculation, 90
F. Schoen, R. Levy, A. Nelson, W. Bernhard, A. Nashef, M. Hawley (1985)
Onset and progression of experimental bioprosthetic heart valve calcification.Laboratory investigation; a journal of technical methods and pathology, 52 5
Meloan Sn, H. Puchtler, Valentine Ls (1972)
Alkaline and acid alizarin red S stains for alkali-soluble and alkali-insoluble calcium deposits.Archives of pathology, 93 3
N. Vyavahare, M. Ogle, F. Schoen, R. Zand, D. Gloeckner, M. Sacks, R. Levy (1999)
Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss.Journal of biomedical materials research, 46 1
A. Wang, J. Woo, M. Wang, M. Sea, R. Ip, P. Li, S. Lui, J. Sanderson (2001)
Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients.Journal of the American Society of Nephrology : JASN, 12 9
Paul Human, Peter Zilla (2001)
Inflammatory and immune processes: the neglected villain of bioprosthetic degeneration?Journal of long-term effects of medical implants, 11 3-4
Y. Pathak, J. Boyd, R. Levy, F. Schoen (1990)
Prevention of calcification of glutaraldehyde pretreated bovine pericardium through controlled release polymeric implants: studies of Fe3+, Al3+, protamine sulphate and levamisole.Biomaterials, 11 9
T. Johnston, E. Bove, S. Bolling, F. Schoen, J. Boyd, G. Golomb, R. Levy (1988)
Local controlled release of 1-hydroxyethylidene diphosphonate using silicone-rubber matrices. Effects of sterilization on in vitro release and in vivo efficacy.ASAIO transactions, 34 3
M. Grynpas, G. Hunter (1988)
Bone mineral and glycosaminoglycans in newborn and mature rabbitsJournal of Bone and Mineral Research, 3
C. Giachelli, Susan Steitz (2000)
Osteopontin: a versatile regulator of inflammation and biomineralization.Matrix biology : journal of the International Society for Matrix Biology, 19 7
Yi Luo, K. Kirker, G. Prestwich (2000)
Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery.Journal of controlled release : official journal of the Controlled Release Society, 69 1
K. Kim, G. Herrera, H. Battarbee (1999)
Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts.The American journal of pathology, 154 3
K. Fukuda, H. Dan, M. Takayama, F. Kumano, M. Saitoh, Seisuke Tanaka (1996)
Hyaluronic acid increases proteoglycan synthesis in bovine articular cartilage in the presence of interleukin-1.The Journal of pharmacology and experimental therapeutics, 277 3
L. Liaw, D. Birk, C. Ballas, J. Whitsitt, J. Davidson, B. Hogan (1998)
Altered wound healing in mice lacking a functional osteopontin gene (spp1).The Journal of clinical investigation, 101 7
J. Kuo, David Swann, Glenn Prestwich (1991)
Chemical modification of hyaluronic acid by carbodiimides.Bioconjugate chemistry, 2 4
W. Lee, Ki Park, D. Han, H. Suh, Jong-Chul Park, Young Kim (2000)
Heparinized bovine pericardium as a novel cardiovascular bioprosthesis.Biomaterials, 21 22
E. Balazs, T. Laurent (1998)
The chemistry, biology and medical applications of hyaluronan and its derivatives
E. Balazs, J. Denlinger (1993)
Viscosupplementation: a new concept in the treatment of osteoarthritis.The Journal of rheumatology. Supplement, 39
Susan Steitz, Mei Speer, M. McKee, L. Liaw, M. Almeida, Hsueh‐Ying Yang, C. Giachelli (2002)
Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification.The American journal of pathology, 161 6
T. Bitter, H. Muir (1962)
A modified uronic acid carbazole reaction.Analytical biochemistry, 4
G. Hunter (1987)
An ion-exchange mechanism of cartilage calcification.Connective tissue research, 16 2
M. Adrian-Scotto, M. Guibbolini, G. Mallet, M. Gaysinski, D. Vasilescu (2002)
23Na NMR Study of the Interaction between Hyaluronan and the bications Ca ++ , Mg ++ and Cu ++Journal of Biomolecular Structure and Dynamics, 19
T. Johnston, C. Webb, F. Schoen, R. Levy (1992)
Assessment of the in vitro transport parameters for ethanehydroxy diphosphonate through a polyurethane membrane. A potential refillable reservoir drug delivery device.ASAIO journal, 38 3
N. Chang, R. Boackle (1985)
Hyaluronic acid-complement interactions--II. Role of divalent cations and gelatin.Molecular immunology, 22 8
G. Hunter (1991)
Role of proteoglycan in the provisional calcification of cartilage. A review and reinterpretation.Clinical orthopaedics and related research, 262
A. Neumann, R. Schinzel, D. Palm, P. Riederer, G. Münch (1999)
High molecular weight hyaluronic acid inhibits advanced glycation endproduct‐induced NF‐κB activation and cytokine expressionFEBS Letters, 453
F. Schoen, J. Kujovich, C. Webb, R. Levy (1987)
Chemically determined mineral content of explanted porcine aortic valve bioprostheses: correlation with radiographic assessment of calcification and clinical data.Circulation, 76 5
R. Levy, J. Wolfrum, F. Schoen, M. Hawley, S. Lund, R. Langer (1985)
Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate.Science, 228 4696
(2011)
E.H. Christopherson Lectureship on International Child HealthAAP News, 32
F. Schoen, R. Levy (1999)
Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives.Journal of biomedical materials research, 47 4
Kim Km (1995)
Apoptosis and calcification.Scanning microscopy, 9
G. Golomb, F. Schoen, M. Smith, J. Lindén, M. Dixon, R. Levy (1987)
The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses.The American journal of pathology, 127 1
T. Wada, M. McKee, Susan Steitz, C. Giachelli (1999)
Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin.Circulation research, 84 2
Davide Campoccia, P. Doherty, Marco Radice, Paola Brun, Giovanni Abatangelo, David Williams (1998)
Semisynthetic resorbable materials from hyaluronan esterification.Biomaterials, 19 23
J. Dunn, L. Marmon (1985)
Mechanisms of Calcification of Tissue ValvesCardiology Clinics, 3
Y. Suzuki, T. Yamaguchi (2005)
Effects of hyaluronic acid on macrophage phagocytosis and active oxygen releaseAgents and Actions, 38
Koen Vercruysse, Glenn Prestwich (1998)
Hyaluronate derivatives in drug delivery.Critical reviews in therapeutic drug carrier systems, 15 5
G. Hunter, K. Wong, J. Kim (1988)
Binding of calcium to glycosaminoglycans: an equilibrium dialysis study.Archives of biochemistry and biophysics, 260 1
André Vincentelli, C. Latrémouille, R. Zegdi, M. Shen, Paul Lajos, J. Chachques, Jean-Noel Fabiani (1998)
Does glutaraldehyde induce calcification of bioprosthetic tissues?The Annals of thoracic surgery, 66 6 Suppl
T. Pouyani, G. Prestwich (1994)
Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials.Bioconjugate chemistry, 5 4
C. Giachelli (1999)
Ectopic calcification: gathering hard facts about soft tissue mineralization.The American journal of pathology, 154 3
J. Lovekamp, N. Vyavahare (2001)
Periodate-mediated glycosaminoglycan stabilization in bioprosthetic heart valves.Journal of biomedical materials research, 56 4
J. Fraser, T. Laurent, U. Laurent (1997)
Hyaluronan: its nature, distribution, functions and turnoverJournal of Internal Medicine, 242
Pathologic calcification is the leading cause of the clinical failure of glutaraldehyde‐fixed bovine pericardium used in bioprosthetic valves. A novel surface modification of glutaraldehyde fixed bovine pericardium was carried out with high molecular weight hyaluronic acid (HA). HA was chemically modified with adipic dihydrazide (ADH) to introduce hydrazide functional groups onto the HA backbone. Glutaraldehyde‐fixed bovine pericardium (GFBP) was modified by grafting this HA to the free aldehyde groups on the tissue via the hydrazide groups. Following a 2‐week subcutaneous implantation in osteopontin (OPN)‐null mice, the calcification of HA‐modified bovine pericardium was drastically reduced (by 84.5%) compared to positive controls (tissue without HA‐modification) (p = 0.005). The calcification‐mitigating effect of HA surface modification was also confirmed by microscopic analysis of explanted tissue stained with Alizarin Red S for calcium. © 2004 Wiley Periodicals, Inc. J Biomed Mater Res 70A: 328–334, 2004
Journal of Biomedical Materials Research Part A – Wiley
Published: Aug 1, 2004
Keywords: bioprosthetic heart valve; bovine pericardium; glycosaminoglycan (GAG); hyaluronic acid (HA); calcification
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.